50 related articles for article (PubMed ID: 26913826)
1. Resveratrol reduces matrix metalloproteinases and alleviates intrahepatic cholestasis of pregnancy in rats.
Chen Z; Hu L; Lu M; Shen Z
Can J Physiol Pharmacol; 2016 Apr; 94(4):402-7. PubMed ID: 26913826
[TBL] [Abstract][Full Text] [Related]
2. Celastrol Attenuates Intrahepatic Cholestasis of Pregnancy by Inhibiting Matrix Metalloproteinases-2 and 9.
Guo J; Wang Y; Wang N; Bai Y; Shi D
Ann Hepatol; 2019; 18(1):40-47. PubMed ID: 31113607
[TBL] [Abstract][Full Text] [Related]
3. The role of Ca
Pan D; Jiang M; Tao G; Shi J; Song Z; Chen R; Wang D
J Obstet Gynaecol; 2024 Dec; 44(1):2345276. PubMed ID: 38685831
[TBL] [Abstract][Full Text] [Related]
4. Effect of polyene phosphatidylcholine/ursodeoxycholic acid/ademetionine on pregnancy outcomes in intrahepatic cholestasis.
Dong XR; Chen QQ; Xue ML; Wang L; Wu Q; Luo TF
World J Clin Cases; 2023 Sep; 11(27):6431-6439. PubMed ID: 37900240
[TBL] [Abstract][Full Text] [Related]
5. Hepatoprotective agents in the management of intrahepatic cholestasis of pregnancy: current knowledge and prospects.
Shan D; Dai S; Chen Q; Xie Y; Hu Y
Front Pharmacol; 2023; 14():1218432. PubMed ID: 37719856
[TBL] [Abstract][Full Text] [Related]
6. Increased PR Interval in Fetuses of Patients with Intrahepatic Cholestasis of Pregnancy.
Rodríguez M; Moreno J; Márquez R; Eltit R; Martinez F; Sepúlveda-Martínez A; Parra-Cordero M
Fetal Diagn Ther; 2016; 40(4):298-302. PubMed ID: 26959834
[TBL] [Abstract][Full Text] [Related]
7. Severe First Trimester Recurrent Intrahepatic Cholestasis of Pregnancy: A Case Report and Literature Review.
Hubschmann AG; Orzechowski KM; Berghella V
AJP Rep; 2016 Mar; 6(1):e38-41. PubMed ID: 26929868
[TBL] [Abstract][Full Text] [Related]
8. [Intrahepatic cholestasis of pregnancy and fetal outcomes: a prospective birth cohort study].
Ge X; Xu YQ; Huang SH; Huang K; Mao LJ; Pan WJ; Hao JH; Niu Y; Yan SQ; Tao FB
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Feb; 37(2):187-91. PubMed ID: 26917512
[TBL] [Abstract][Full Text] [Related]
9. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.
Chappell LC; Bell JL; Smith A; Linsell L; Juszczak E; Dixon PH; Chambers J; Hunter R; Dorling J; Williamson C; Thornton JG;
Lancet; 2019 Sep; 394(10201):849-860. PubMed ID: 31378395
[TBL] [Abstract][Full Text] [Related]
10. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
[TBL] [Abstract][Full Text] [Related]
11. Advances of natural activators for Nrf2 signaling pathway on cholestatic liver injury protection: a review.
He L; Guo C; Peng C; Li Y
Eur J Pharmacol; 2021 Nov; 910():174447. PubMed ID: 34461126
[TBL] [Abstract][Full Text] [Related]
12. Hepatoprotective activities of rosmarinic acid against extrahepatic cholestasis in rats.
Lin SY; Wang YY; Chen WY; Liao SL; Chou ST; Yang CP; Chen CJ
Food Chem Toxicol; 2017 Oct; 108(Pt A):214-223. PubMed ID: 28789951
[TBL] [Abstract][Full Text] [Related]
13. Epigallocatechin-3-gallate ameliorates intrahepatic cholestasis of pregnancy by inhibiting matrix metalloproteinase-2 and matrix metalloproteinase-9.
Zhang M; Xu M
Fundam Clin Pharmacol; 2017 Oct; 31(5):526-533. PubMed ID: 28477356
[TBL] [Abstract][Full Text] [Related]
14. Up-regulation of BSEP and MRP2 by Calculus Bovis administration in 17α-ethynylestradiol-induced cholestasis: Involvement of PI3K/Akt signaling pathway.
Wu T; Zhang Q; Li J; Chen H; Wu J; Song H
J Ethnopharmacol; 2016 Aug; 190():22-32. PubMed ID: 27237619
[TBL] [Abstract][Full Text] [Related]
15. Exploration of the Molecular Basis of Forsythia Fruit in the Prevention and Treatment of Cholestatic Liver Injury through Network Pharmacology and Molecular Docking.
Fu K; Li Y; Dai S; Li Y
Nutrients; 2023 Apr; 15(9):. PubMed ID: 37432229
[TBL] [Abstract][Full Text] [Related]
16. Effect of Resveratrol on Pregnancy, Prenatal Complications and Pregnancy-Associated Structure Alterations.
Ramli I; Posadino AM; Giordo R; Fenu G; Fardoun M; Iratni R; Eid AH; Zayed H; Pintus G
Antioxidants (Basel); 2023 Jan; 12(2):. PubMed ID: 36829900
[TBL] [Abstract][Full Text] [Related]
17. Molecular Pathogenesis of Intrahepatic Cholestasis of Pregnancy.
Xiao J; Li Z; Song Y; Sun Y; Shi H; Chen D; Zhang Y
Can J Gastroenterol Hepatol; 2021; 2021():6679322. PubMed ID: 34195157
[TBL] [Abstract][Full Text] [Related]
18. The Effect of Glutamine Supplementation on Oxidative Stress and Matrix Metalloproteinase 2 and 9 After Exhaustive Exercise.
Nemati A; Alipanah-Moghadam R; Molazadeh L; Naghizadeh Baghi A
Drug Des Devel Ther; 2019; 13():4215-4223. PubMed ID: 31849453
[TBL] [Abstract][Full Text] [Related]
19. Relations of neuropeptide Y and heme oxygenase-1 expressions with fetal brain injury in rats with intrahepatic cholestasis of pregnancy.
Li H; Liu B; Gu C; Zeng X; Liu Y; Zhang S; Gong H; Shao Y; Yao Z; An R
Acta Cir Bras; 2019 May; 34(4):e201900401. PubMed ID: 31066785
[TBL] [Abstract][Full Text] [Related]
20. Resveratrol: A Double-Edged Sword in Health Benefits.
Salehi B; Mishra AP; Nigam M; Sener B; Kilic M; Sharifi-Rad M; Fokou PVT; Martins N; Sharifi-Rad J
Biomedicines; 2018 Sep; 6(3):. PubMed ID: 30205595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]